Negative regulation of the tumor suppressor p53 gene by microRNAs

Oncogene

Volumn 30, Issue 7, 2011, Pages 843-853

  Kumar, M ^a,c   Lu, Z ^a,d   Takwi, A A L ^a   Chen, W ^a,d   Callander, N S ^b   Ramos, K S ^a   Young, K H ^b   Li, Y ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c ASSAM UNIVERSITY   (India)

^d CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

apoptosis; cell cycle arrest; microRNA; multiple myeloma; p53; senescence

Indexed keywords

MICRORNA; PROTEIN P53;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; ASSAY; CELL CYCLE ARREST; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MYELOMA CELL; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL AGING; CELL CYCLE; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951812882     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.457     Document Type: Article

References (39)

1. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Bartel DP. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
3. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. (2007). p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298-1307. (Pubitemid 47176893)
4. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501. (Pubitemid 28538613)
5. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. (2007). Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752. (Pubitemid 46856245)
6. Chng WJ, Price-Troska T, Gonzalez-Paz N, Van Wier S, Jacobus S, Blood E et al. (2007). Clinical significance of TP53 mutation in myeloma. Leukemia 21: 582-584.
7. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. (2004). Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64: 1546-1558. (Pubitemid 38235629)
8. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
9. Hanahan D, Weinberg RA. (2000). The Hallmarks of Cancer. Cell 100: 57-70. (Pubitemid 30046295)
10. Harris SL, Levine AJ. (2005). The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908. (Pubitemid 40638098)
11. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134. (Pubitemid 47014436)
12. Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song JS et al. (2010). Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 38: 689-699.
13. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. (2004). Human microRNA targets. PLoS Biol 2: e363.
14. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635-647. (Pubitemid 40343076)
15. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y et al. (2009). The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136: 1689-1700.
16. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. (2005). Combinatorial microRNA target predictions. Nat Genet 37: 495.
17. Kruse J-P, Gu W. (2009). Modes of p53 Regulation. Cell 137: 609-622.
18. Le MTN, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V et al. (2009). MicroRNA-125b is a novel negative regulator of p53. Genes & Dev 23: 862-876.
19. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
20. Mayer B, Oberbauer R. (2003). Mitochondrial regulation of apoptosis. News Physiol Sci 18: 89-94. (Pubitemid 36782796)
21. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM et al. (2006). A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217. (Pubitemid 44380294)
22. Park SY, Lee JH, Ha M, Nam JW, Kim VN. (2009). miR-29 miRNAs activate p53 by targeting p85a and CDC42. Nat Struct Mol Biol 16: 23-29.
23. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008). E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286. (Pubitemid 351318375)
24. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D et al. (2008). MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 105: 12885-12890.
25. Prendergast NJ, Atkins MR, Schatte EC, Paulson DF, Walther PJ. (1996). p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma. J Urol 155: 1685-1692. (Pubitemid 26126976)
26. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743. (Pubitemid 46856247)
27. Riley T, Sontag E, Chen P, Levine A. (2008). Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
28. Suzuki S, Adachi A, Hiraiwa A, Ohashi M, Ishibashi M, Kiyono T. (1998). Cloning and characterization of human MCM7 promoter. Gene 216: 85-91. (Pubitemid 28389105)
29. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A et al. (2007). Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593. (Pubitemid 47327945)
30. Toledo F, Wahl GM. (2006). Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 6: 909-923. (Pubitemid 44862676)
31. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. (2007). Restoration of p53 function leads to tumour regression in vivo. Nature 445: 661-665. (Pubitemid 46232887)
32. Voeller HJ, Sugars LY, Pretlow T, Gelmann EP. (1994). p53 oncogene mutations in human prostate cancer specimens. J Urol 151: 492-495. (Pubitemid 24047041)
33. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408: 307-310.
34. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
35. Vousden KH, Prives C. (2009). Blinded by the light: the growing complexity of p53. Cell 137: 413-431.
36. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L et al. (1999). GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 96: 3706-3711. (Pubitemid 29168974)
37. Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, Wang S et al. (2008). An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood 112: 4235-4246.
38. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660. (Pubitemid 46232886)
39. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. (Pubitemid 43357945)